Comparison 4. Clarithromycin (1 g/day) versus placebo.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 1 Failure to enter clinical remission at 12 weeks | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
| 2 Failure to have clinical response at 12 weeks | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
| 3 Adverse events | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
| 4 Withdrawal due to adverse events | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected |